Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02006394 · ClinicalTrials.gov registry record · NA
Novel Dietary Interventions for Treating Insulin Resistance
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT02006394: Completed NA study, sponsored by University of California, San Diego.
NCT02006394 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02006394, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
Clinical and rodent studies have demonstrated the impact of specific dietary factors in modulating inflammation-related diseases including insulin resistance, type 2 diabetes, and cardiovascular disease. Such dietary factors include polyunsaturated fats, polyphenols, and glycemic index. The investigators know from previous studies in the literature that reducing the glycemic index and increasing the omega-3 fat and polyphenol content of the diet results in improved metabolic indices and reduced inflammation. These improvements can be observed even within the context of persistent obesity. The investigators will implement a reduced-calorie, multi-pronged dietary approach for improving insulin sensitivity and reducing inflammation in obese subjects with the metabolic syndrome. The active diet will include reduced glycemic index foods together with omega-3 fats and polyphenol supplements. The primary hypothesis is that the dietary combination of reduced glycemic index foods, omega-3 fats and polyphenols will work to reduce insulin resistance and inflammation more efficiently than a placebo-controlled, calorie- and macronutrient-matched diet in obese subjects with the metabolic syndrome.
Primary Outcome
Fasting plasma insulin, Homeostasis Model of Assessment - Insulin Resistance (HOMA-IR)
Interventions
- DIETARY_SUPPLEMENT Fish Oil
- DIETARY_SUPPLEMENT Polyphenol Capsules
- DIETARY_SUPPLEMENT Corn Oil Capsules
- DIETARY_SUPPLEMENT Corn starch capsules
- OTHER Reduced glycemic index bread products
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2012-01 |
| Est. Completion | 2013-11 |
| Phase | NA |
What the finished NCT02006394 record still lists
NCT02006394 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 5 interventions - of which Fish Oil is the first listed.
NCT02006394 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02006394 about?
NCT02006394 is a clinical study titled "Novel Dietary Interventions for Treating Insulin Resistance". Clinical and rodent studies have demonstrated the impact of specific dietary factors in modulating inflammation-related diseases including insulin resistance, type 2 diabetes, and cardiovascular disease. Such dietary factors include polyunsaturated fats, polyphenols, and glycemic index. The investig...
What is the current status of trial NCT02006394?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2012-01. Estimated completion is 2013-11.
What interventions are being tested in trial NCT02006394?
The interventions under investigation include: Fish Oil (DIETARY_SUPPLEMENT), Polyphenol Capsules (DIETARY_SUPPLEMENT), Corn Oil Capsules (DIETARY_SUPPLEMENT), Corn starch capsules (DIETARY_SUPPLEMENT), Reduced glycemic index bread products (OTHER).
Who is sponsoring clinical trial NCT02006394?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02006394's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia